Comparison of Lisdexamfetamine Dimesylate With Atomoxetine HCl in Attention-Deficit/Hyperactivity Disorder (ADHD) Subjects With an Inadequate Response to Methylphenidate
Public ClinicalTrials.gov record NCT01106430. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3b, Double-blind, Randomised, Active-controlled, Parallel Group Study to Assess the Time to Response of Lisdexamfetamine Dimesylate to Atomoxetine Hydrochloride in Children and Adolescents Aged 6-17 Years With Attention-Deficit/Hyperactivity Disorder (ADHD) Who Have Had an Inadequate Response to Methylphenidate Therapy
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study will evaluate how long it takes for ADHD symptoms to improve in subjects who are judged by the Investigator to have had an inadequate response to methylphenidate therapy. The study will also test the safety of Lisdexamfetamine Dimesylate and how well it works.
Study identification
- NCT ID
- NCT01106430
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 267 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 6 Years to 17 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 28, 2010 (Actual)
- Primary completion
- Jul 19, 2012 (Actual)
- Completion
- Jul 19, 2012 (Actual)
- Last update posted
- Jun 11, 2021
2010 – 2012
United States locations
- U.S. sites
- 34
- U.S. states
- 25
- U.S. cities
- 34
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Harmonex Neuroscience Research, Inc | Dothan | Alabama | 36303 | — |
| Clinical Study Centers, LLC | Little Rock | Arkansas | 72205 | — |
| Shanti Clinical Trials | Colton | California | 92324 | — |
| Psychiatric Centers at San Diego Feighner Research | San Diego | California | 92108 | — |
| Elite Clinical Trials, Inc. | Wildomar | California | 92595 | — |
| Sarkis Clinical Trials | Gainesville | Florida | 32607 | — |
| Amedica Research Institute, Inc. | Hialeah | Florida | 33013 | — |
| Fidelity Clinical Research, Inc. | Lauderhill | Florida | 33319 | — |
| Clinical Neuroscience Solutions, INC | Orlando | Florida | 32806 | — |
| Northwest Behavioral Research Center | Roswell | Georgia | 30076 | — |
| Capstone Clinical Research | Libertyville | Illinois | 60048 | — |
| Baber Psychiatric Associates | Naperville | Illinois | 60563 | — |
| Clinco | Terre Haute | Indiana | 47802 | — |
| Heartland Research Associates, LLC | Wichita | Kansas | 67207 | — |
| Four Rivers Clinical Research, Inc | Paducah | Kentucky | 42003 | — |
| Louisianna Research Associates | New Orleans | Louisiana | 70114 | — |
| Office of Marc Hertzman, MD, PC | Rockville | Maryland | 20852 | — |
| Rochester Center for Behavioral Medicine | Rochester Hills | Michigan | 48307 | — |
| Midwest Research Group/Saint Charles Psychiatric Associates | Saint Charles | Missouri | 63301 | — |
| Premier Psychiatric Research Institute, LLC | Lincoln | Nebraska | 68526 | — |
| Center for Psychiatry and Behavioral Medicine, Inc. | Las Vegas | Nevada | 89128 | — |
| Children's Specialized Hospital | Toms River | New Jersey | 08755 | — |
| Richmond Behavioral Associates | Staten Island | New York | 10312 | — |
| Triangle Neuropsychiatry, PLLC | Durham | North Carolina | 27707 | — |
| Innovis Health | Fargo | North Dakota | 58103 | — |
| IPS Research Company | Oklahoma City | Oklahoma | 73103 | — |
| Cyn3rgy Research | Gresham | Oregon | 97030 | — |
| CRI Worldwide, LLC Kirkbride Division | Philadelphia | Pennsylvania | 19139 | — |
| Future Search Clinical Trials | Austin | Texas | 78731 | — |
| Red Oak Psychiatry Association, PA | Houston | Texas | 77090 | — |
| Western Clinical Investigations | Lubbock | Texas | 79423 | — |
| Cerebral Research, LLC | San Antonio | Texas | 78247 | — |
| Lifetree Clinical Research | Salt Lake City | Utah | 84106 | — |
| Eastside Therapeutic Resource | Kirkland | Washington | 98033 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 30 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01106430, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 11, 2021 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01106430 live on ClinicalTrials.gov.